Ovarian Cancer
A Phase 1b/2 Randomized, Controlled Study of AVB-S6-500 in Combination with Pegylated Liposomal Doxorubicin or Paclitaxel in Patients with Platinum-resistant Recurrent Ovarian Cancer (AVB500-OC-002)
- Details
ClinicalTrials.gov ID:
NCT03639246
Diagnosis Type:
NA
USOR Number:
- Address
603 N Wilmot Rd, Suite 151
Tucson, AZ 85711
P: (520) 886-0206